olprinone has been researched along with Heart Failure in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Pan, Y; Wang, X; Zhang, H | 1 |
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Nakanishi, R; Oka, T; Watanabe, I | 1 |
| Inoue, H; Murata, H; Sumikawa, K | 1 |
| Fujiwara, H; Fukuhara, R; Miyamoto, T; Nishi, K; Saijo, S; Sato, Y; Takatsu, Y; Taniguchi, R; Toma, M | 1 |
| Mizushige, K; Suzuki, H; Ueda, T; Yukiiri, K | 1 |
| Inagaki, M; Ishikawa, S; Mitsui, T; Onizuka, M; Sato, Y; Tomoyasu, M; Yamamoto, T | 1 |
| Kohno, M; Mizushige, K; Takahashi, T; Ueda, T; Yukiiri, K | 1 |
| Goto, Y | 1 |
| Enomoto, K; Honda, M; Ishinaga, Y; Kuramochi, T; Kuzuo, H; Morioka, S; Takabatake, T; Tanaka, K | 1 |
| Holubarsch, C | 1 |
| Adachi, H; Tanaka, H | 1 |
| Baba, T; Goto, Y; Kanda, M; Noguchi, T; Nonogi, H; Sumida, H; Yasuda, S | 1 |
| Koide, H; Nakamura, T; Shimada, N; Suzuki, S; Ushiyama, C | 1 |
| Igarashi, T; Ogawa, T; Ohhara, H; Sawada, K; Takeda, M | 1 |
| Hayashi, M; Himura, Y; Kawai, C; Kumada, T; Nakamura, Y; Tanio, H | 1 |
| Asanoi, H; Ishizaka, S; Sasayama, S | 1 |
| Daiku, Y; Igarashi, T; Katoh, H; Ogawa, T; Ohhara, H; Takeda, M | 1 |
3 review(s) available for olprinone and Heart Failure
| Article | Year |
|---|---|
Systematic review and meta-analysis of the efficacy of olprinone and MEFV gene in treating heart failure.
Topics: Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 2023 |
Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects.
Topics: Carotid Arteries; Cerebrovascular Circulation; Heart Failure; Humans; Imidazoles; Muscle, Smooth, Vascular; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Treatment Outcome; Vasodilation | 2002 |
[How to use PDE III inhibitors].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridones; Randomized Controlled Trials as Topic | 2007 |
2 trial(s) available for olprinone and Heart Failure
| Article | Year |
|---|---|
Improvement of cerebral blood flow by olprinone, a phosphodiesterase-3 inhibitor, in mild heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cerebral Cortex; Cerebrovascular Circulation; Female; Heart Failure; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Pyridones; Radionuclide Imaging; Severity of Illness Index | 2003 |
Effect of phosphodiesterase III inhibitor on plasma concentrations of endothelin-1 and tumour necrosis factor in patients with acute heart failure.
Topics: Adult; Cardiotonic Agents; Endothelin-1; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Pyridones; Tumor Necrosis Factor-alpha | 2002 |
12 other study(ies) available for olprinone and Heart Failure
| Article | Year |
|---|---|
Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Disease Progression; Female; Heart Failure; Hospitalization; Humans; Imidazoles; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Progression-Free Survival; Pyridones; Recovery of Function; Retrospective Studies; Time Factors | 2020 |
Anesthetic management of a patient undergoing liver transplantation who had previous coronary artery bypass grafting using an in situ right gastroepiploic artery.
Topics: Anesthesia; Anti-Arrhythmia Agents; Cardiotonic Agents; Coronary Artery Bypass; Gastroepiploic Artery; Heart Failure; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Nicorandil; Pyridones | 2010 |
Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Female; Follow-Up Studies; Heart Failure; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Outpatients; Pyridones; Severity of Illness Index; Survival Rate; Systole; Treatment Outcome | 2012 |
Effect of phosphodiesterase III inhibitor (Olprinone) on thoracic duct lymph flow in anesthetized sheep with experimentally induced heart failure by endothelin-1.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiac Output; Central Venous Pressure; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Endothelin-1; Enzyme Inhibitors; Female; Heart Failure; Imidazoles; Lung; Male; Models, Cardiovascular; Pyridones; Renal Circulation; Sheep; Shock, Cardiogenic; Thoracic Duct; Time Factors; Treatment Outcome; Vascular Resistance | 2002 |
Contrasting effects of isoproterenol and phosphodiesterase III inhibitor on intracellular calcium transients in cardiac myocytes from failing hearts.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Fura-2; Heart; Heart Failure; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Monocrotaline; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Sprague-Dawley | 1994 |
New inotropic concepts: rationale for and differences between calcium sensitizers and phosphodiesterase inhibitors.
Topics: Animals; Calcium; Cardiotonic Agents; Deoxyepinephrine; Energy Metabolism; Guinea Pigs; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinolines; Thiadiazines | 1997 |
Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Pressure; Cardiotonic Agents; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Failure; Hemodynamics; Hormones; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Swine; Vascular Resistance; Ventricular Function, Left | 1997 |
Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Amrinone; Creatinine; Diuresis; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Treatment Outcome | 1999 |
[Effects of the new cardiotonic agent loprinone hydrochloride (E-1020) on left ventricular diameter in normal and experimental heart failure dogs and its action potential characteristics in isolated guinea pig cardiac muscles and sinus nodes].
Topics: Action Potentials; Animals; Atrioventricular Node; Cardiotonic Agents; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart Failure; Heart Ventricles; Hemodynamics; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Pyridones | 1992 |
Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized dogs.
Topics: Acute Disease; Animals; Cardiotonic Agents; Dogs; Dopamine; Heart Failure; Hemodynamics; Imidazoles; Mitral Valve Insufficiency; Myocardial Contraction; Pyridones; Stimulation, Chemical | 1991 |
Mechanics of contraction and relaxation of the ventricle in experimental heart failure produced by rapid ventricular pacing in the conscious dog.
Topics: Animals; Cardiac Pacing, Artificial; Dobutamine; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Ventricular Function, Left | 1991 |
Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Topics: Anesthesia; Animals; Cardiotonic Agents; Coronary Circulation; Dogs; Female; Heart Failure; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Pyridones; Regional Blood Flow; Time Factors | 1989 |